Valneva: Health Canada Approves Chikungunya Vaccine – Quick Facts
- Stock Market Stocks to buy Stocks to sell
admin
- 0
- 1 minute read
(RTTNews) – Valneva SE (VALN) announced that Health Canada has approved IXCHIQ, the company’s single-dose vaccine for the prevention of disease caused by the chikungunya virus in individuals 18 years of age and older. IXCHIQ is the world’s only licensed chikungunya vaccine.
:max_bytes(150000):strip_icc():format(jpeg)/FlyFirstClassforCheap-d3852e14d3984fddb9a46fcb17fc93c2.jpg "How to Fly First Class for Cheap")
:max_bytes(150000):strip_icc():format(jpeg)/GettyImages-506997606-3aeda39d7c734e459725400f855c816d.jpg "Is Shopping at Big-Box Stores Worth It? Factors to Consider")
:max_bytes(150000):strip_icc():format(jpeg)/GettyImages-1169041231-5052d200552d467baab33417938984a3.jpg "10 Low-Risk Income Sources for a Safer Retirement")
